Also known as آسٹیوپوروسس مینجمنٹ
Cardiologist
MBBS, MSc Diabetes (UK), MSc (Cardiology), Diplomat Endocrinology
Cardiologist
MBBS, MSc Diabetes (UK), MSc (Cardiology), Diplomat Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Diabetologist
M.B.B.S., F.C.P.S. (Medicine), MRCP (UK), F.C.P.S. (Nephrology)
Internal Medicine Specialist
MBBS, FCPS
Diabetologist
M.B.B.S., DIP DAB
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine), ICMT
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
M.B.B.S , F.C.P.S
Internal Medicine Specialist
M.B.B.S., M.R.C.P (UK), MRCP SCE Endocrinology and diabetes , PG Endocrinology , Certificate for obesity management
Internal Medicine Specialist
M.B.B.S., M.R.C.P (UK), MRCP SCE Endocrinology and diabetes , PG Endocrinology , Certificate for obesity management
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Internal Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures